항 CLDN-5 항체, 및 그 항체를 함유하는 의약

새로운, CLDN-5 특이성이 높은, CLDN-5 의 세포 외 도메인을 인식하는 분자를 제공한다는 과제를, Claudin-5 단백질의 세포 외 영역의 입체 구조 또는 1 차 구조를 특이적으로 인식하는 항체에 의해 해결한다. An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OKADA YOSHIAKI, SAWASAKI TATSUYA, HASHIMOTO YOSUKE, TAKEDA HIROYUKI, ENDO KOHKI, KONDOH MASUO, YAGI KIYOHITO, DOI TAKEFUMI, TAMURA MAKI
Format: Patent
Sprache:kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OKADA YOSHIAKI
SAWASAKI TATSUYA
HASHIMOTO YOSUKE
TAKEDA HIROYUKI
ENDO KOHKI
KONDOH MASUO
YAGI KIYOHITO
DOI TAKEFUMI
TAMURA MAKI
description 새로운, CLDN-5 특이성이 높은, CLDN-5 의 세포 외 도메인을 인식하는 분자를 제공한다는 과제를, Claudin-5 단백질의 세포 외 영역의 입체 구조 또는 1 차 구조를 특이적으로 인식하는 항체에 의해 해결한다. An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved by an antibody which specifically recognizes a three-dimensional structure or a primary structure of an extracellular domain of a Claudin-5 protein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20200004810A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20200004810A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20200004810A3</originalsourceid><addsrcrecordid>eNrjZLB4O3WtgrOPi5-uqQKQ-WbTFh2F1xv6FV5t3wHlv166B8ha8WbOgrdTZ7zumqLwZu6MN1P38jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSSeO8gIwMjAyAwsTA0cDQmThUANoM7QA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>항 CLDN-5 항체, 및 그 항체를 함유하는 의약</title><source>esp@cenet</source><creator>OKADA YOSHIAKI ; SAWASAKI TATSUYA ; HASHIMOTO YOSUKE ; TAKEDA HIROYUKI ; ENDO KOHKI ; KONDOH MASUO ; YAGI KIYOHITO ; DOI TAKEFUMI ; TAMURA MAKI</creator><creatorcontrib>OKADA YOSHIAKI ; SAWASAKI TATSUYA ; HASHIMOTO YOSUKE ; TAKEDA HIROYUKI ; ENDO KOHKI ; KONDOH MASUO ; YAGI KIYOHITO ; DOI TAKEFUMI ; TAMURA MAKI</creatorcontrib><description>새로운, CLDN-5 특이성이 높은, CLDN-5 의 세포 외 도메인을 인식하는 분자를 제공한다는 과제를, Claudin-5 단백질의 세포 외 영역의 입체 구조 또는 1 차 구조를 특이적으로 인식하는 항체에 의해 해결한다. An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved by an antibody which specifically recognizes a three-dimensional structure or a primary structure of an extracellular domain of a Claudin-5 protein.</description><language>kor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200114&amp;DB=EPODOC&amp;CC=KR&amp;NR=20200004810A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200114&amp;DB=EPODOC&amp;CC=KR&amp;NR=20200004810A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OKADA YOSHIAKI</creatorcontrib><creatorcontrib>SAWASAKI TATSUYA</creatorcontrib><creatorcontrib>HASHIMOTO YOSUKE</creatorcontrib><creatorcontrib>TAKEDA HIROYUKI</creatorcontrib><creatorcontrib>ENDO KOHKI</creatorcontrib><creatorcontrib>KONDOH MASUO</creatorcontrib><creatorcontrib>YAGI KIYOHITO</creatorcontrib><creatorcontrib>DOI TAKEFUMI</creatorcontrib><creatorcontrib>TAMURA MAKI</creatorcontrib><title>항 CLDN-5 항체, 및 그 항체를 함유하는 의약</title><description>새로운, CLDN-5 특이성이 높은, CLDN-5 의 세포 외 도메인을 인식하는 분자를 제공한다는 과제를, Claudin-5 단백질의 세포 외 영역의 입체 구조 또는 1 차 구조를 특이적으로 인식하는 항체에 의해 해결한다. An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved by an antibody which specifically recognizes a three-dimensional structure or a primary structure of an extracellular domain of a Claudin-5 protein.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB4O3WtgrOPi5-uqQKQ-WbTFh2F1xv6FV5t3wHlv166B8ha8WbOgrdTZ7zumqLwZu6MN1P38jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSSeO8gIwMjAyAwsTA0cDQmThUANoM7QA</recordid><startdate>20200114</startdate><enddate>20200114</enddate><creator>OKADA YOSHIAKI</creator><creator>SAWASAKI TATSUYA</creator><creator>HASHIMOTO YOSUKE</creator><creator>TAKEDA HIROYUKI</creator><creator>ENDO KOHKI</creator><creator>KONDOH MASUO</creator><creator>YAGI KIYOHITO</creator><creator>DOI TAKEFUMI</creator><creator>TAMURA MAKI</creator><scope>EVB</scope></search><sort><creationdate>20200114</creationdate><title>항 CLDN-5 항체, 및 그 항체를 함유하는 의약</title><author>OKADA YOSHIAKI ; SAWASAKI TATSUYA ; HASHIMOTO YOSUKE ; TAKEDA HIROYUKI ; ENDO KOHKI ; KONDOH MASUO ; YAGI KIYOHITO ; DOI TAKEFUMI ; TAMURA MAKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20200004810A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>OKADA YOSHIAKI</creatorcontrib><creatorcontrib>SAWASAKI TATSUYA</creatorcontrib><creatorcontrib>HASHIMOTO YOSUKE</creatorcontrib><creatorcontrib>TAKEDA HIROYUKI</creatorcontrib><creatorcontrib>ENDO KOHKI</creatorcontrib><creatorcontrib>KONDOH MASUO</creatorcontrib><creatorcontrib>YAGI KIYOHITO</creatorcontrib><creatorcontrib>DOI TAKEFUMI</creatorcontrib><creatorcontrib>TAMURA MAKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OKADA YOSHIAKI</au><au>SAWASAKI TATSUYA</au><au>HASHIMOTO YOSUKE</au><au>TAKEDA HIROYUKI</au><au>ENDO KOHKI</au><au>KONDOH MASUO</au><au>YAGI KIYOHITO</au><au>DOI TAKEFUMI</au><au>TAMURA MAKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>항 CLDN-5 항체, 및 그 항체를 함유하는 의약</title><date>2020-01-14</date><risdate>2020</risdate><abstract>새로운, CLDN-5 특이성이 높은, CLDN-5 의 세포 외 도메인을 인식하는 분자를 제공한다는 과제를, Claudin-5 단백질의 세포 외 영역의 입체 구조 또는 1 차 구조를 특이적으로 인식하는 항체에 의해 해결한다. An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved by an antibody which specifically recognizes a three-dimensional structure or a primary structure of an extracellular domain of a Claudin-5 protein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language kor
recordid cdi_epo_espacenet_KR20200004810A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
title 항 CLDN-5 항체, 및 그 항체를 함유하는 의약
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A53%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OKADA%20YOSHIAKI&rft.date=2020-01-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20200004810A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true